PHARBIL Pharma GmbH

PHARBIL Pharma GmbH, Bielefeld, is a 94% subsidiary of NextPharma GmbH and is overseen by NextPharma Technologies Holding Ltd., London. All operations take place at the Bielefeld site; the company is internally divided into the main areas Production and Development/Contract Analytics, with Development providing production-near services such as galenics and contract analytics. The production focus is on solid dosage forms, specifically pellets and organic granulates, which are encapsulated, pressed into tablets or shipped as bulk; in 2006 the production expansion for coating at the Bielefeld site was completed. The sales market is exclusively in Europe with a focus on Germany and Western European countries, and the customer base includes both generics companies and groups marketing original products.